PROCEPT BioRobotics (PRCT) Insider Trading & Ownership $52.62 -1.14 (-2.12%) As of 02:09 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROCEPT BioRobotics (NASDAQ:PRCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$62.84 M Get PRCT Insider Trade Alerts Want to know when executives and insiders are buying or selling PROCEPT BioRobotics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PRCT Insider Buying and Selling by Quarter Remove Ads PROCEPT BioRobotics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/18/2025Hisham ShiblaqEVPSell247$57.06$14,093.82 3/18/2025Kevin WatersCFOSell733$57.06$41,824.98 3/18/2025Reza ZadnoCEOSell5,475$57.06$312,403.50 12/4/2024Alaleh NouriEVPSell28,092$97.13$2,728,575.96 12/4/2024Reza ZadnoCEOSell26,423$97.22$2,568,844.06 11/27/2024Reza ZadnoCEOSell26,420$97.83$2,584,668.60 11/20/2024Reza ZadnoCEOSell26,420$92.57$2,445,699.40 11/7/2024Antal Rohit DesaiDirectorSell34,000$95.39$3,243,260.00 11/5/2024Antal Rohit DesaiDirectorSell33,000$96.60$3,187,800.00 10/30/2024Reza ZadnoCEOSell288,461$91.00$26,249,951.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/15/2024Kevin WatersCFOSell25,000$72.47$1,811,750.00 9/16/2024Kevin WatersCFOSell25,000$82.51$2,062,750.00 9/12/2024Antal Rohit DesaiDirectorSell44,867$80.11$3,594,295.37 9/10/2024Antal Rohit DesaiDirectorSell36,500$76.18$2,780,570.00 9/5/2024Antal Rohit DesaiDirectorSell13,305$76.37$1,016,102.85 9/3/2024Antal Rohit DesaiDirectorSell35,220$76.12$2,680,946.40 6/17/2024Alaleh NouriEVPSell10,000$62.18$621,800.00 6/10/2024Hisham ShiblaqEVPSell26,046$68.24$1,777,379.04 5/3/2024Alaleh NouriEVPSell30,432$62.97$1,916,303.04 5/1/2024Thomas M KrummelDirectorSell20,000$60.00$1,200,000.00 (Data available from 1/1/2013 forward) PRCT Insider Trading Activity - Frequently Asked Questions Who is on PROCEPT BioRobotics's Insider Roster? The list of insiders at PROCEPT BioRobotics includes Alaleh Nouri, Antal Rohit Desai, Frederic H Moll, Hisham Shiblaq, Kevin Waters, Morgan Colby Wood, Reza Zadno, and Thomas M Krummel. Learn more on insiders at PRCT. What percentage of PROCEPT BioRobotics stock is owned by insiders? 17.40% of PROCEPT BioRobotics stock is owned by insiders. Learn more on PRCT's insider holdings. Which PROCEPT BioRobotics insiders have been selling company stock? The following insiders have sold PRCT shares in the last 24 months: Alaleh Nouri ($7,832,650.70), Antal Rohit Desai ($16,502,974.62), Frederic H Moll ($3,061,250.00), Hisham Shiblaq ($1,791,472.86), Kevin Waters ($11,616,575.75), Morgan Colby Wood ($804,750.00), Reza Zadno ($34,853,193.02), and Thomas M Krummel ($1,200,000.00). How much insider selling is happening at PROCEPT BioRobotics? Insiders have sold a total of 1,089,647 PROCEPT BioRobotics shares in the last 24 months for a total of $77,662,866.95 sold. PROCEPT BioRobotics Key ExecutivesDr. Reza Zadno Ph.D. (Age 69)President, CEO & Director Compensation: $1.13MMr. Kevin Waters (Age 47)Executive VP & CFO Compensation: $680.11k1 recent tradesMs. Alaleh Nouri (Age 45)EVP, Chief Legal Officer & Corporate Secretary Compensation: $605.84k1 recent tradesMr. Hisham Shiblaq (Age 48)Executive VP & Chief Commercial Officer Compensation: $645.95k1 recent tradesMr. Mohan F. Sancheti (Age 60)Senior Vice President of Operations Mr. Barry TemplinExecutive VP of Technology & Clinical DevelopmentMr. Matthew James Bacso C.F.A.Vice President of Investor RelationsMs. Stacey L. Porter (Age 48)Chief People Officer Mr. Bijesh ChandranSenior Vice President of Regulatory Affairs & Quality Assurance More Insider Trading Tools from MarketBeat Related Companies PEN Insider Trading GKOS Insider Trading NARI Insider Trading INSP Insider Trading BLCO Insider Trading SLNO Insider Trading IRTC Insider Trading NVST Insider Trading TMDX Insider Trading LIVN Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market This page (NASDAQ:PRCT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRCT Stock Free PRCT Stock Alerts